1991
DOI: 10.1016/0887-8994(91)90070-2
|View full text |Cite
|
Sign up to set email alerts
|

Focal cerebral deficits in severe hypomagnesemia

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
8
0

Year Published

2007
2007
2018
2018

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 26 publications
(8 citation statements)
references
References 6 publications
0
8
0
Order By: Relevance
“…But patients with hypomagnesaemia may also present many further neurological symptoms such as seizures, paraesthesias, myoclonus, fasciculations, ataxia, dysarthria, irritability, disorientation, psychosis, vertigo and confusion 3. Recurrent symptomatology4 and even focal cerebral deficits such as hemiparesis5 has been described.…”
Section: Discussionmentioning
confidence: 99%
“…But patients with hypomagnesaemia may also present many further neurological symptoms such as seizures, paraesthesias, myoclonus, fasciculations, ataxia, dysarthria, irritability, disorientation, psychosis, vertigo and confusion 3. Recurrent symptomatology4 and even focal cerebral deficits such as hemiparesis5 has been described.…”
Section: Discussionmentioning
confidence: 99%
“…Although they are unlikely to occur without concomitant mental status alteration, hypocalcemic seizures may be focal in nature and mimic a monoparesis [12]. Similarly, severe hypomagnesemia (b0.8 mEq/L) occasionally presents with focal neurologic deficits [13]. When the results of blood glucose and electrolyte determinations are not immediately available, administration of aliquots of naloxone and/or flumazenil may be considered in the interim to antagonize the central effects of administered opioids or benzodiazepines, but must be weighed against potential adverse effects of these drugs.…”
Section: Discussionmentioning
confidence: 96%
“…Hypomagnesemia is associated with multiple neurological abnormalities, including irritability, seizures, paralysis, and choreiform movements [36,37]. The trace element manganese is routinely administered intravenously to TPN patients at a dosage of 100 to 800 μg/d.…”
Section: Indicationsmentioning
confidence: 99%